JP2007501817A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501817A5
JP2007501817A5 JP2006522915A JP2006522915A JP2007501817A5 JP 2007501817 A5 JP2007501817 A5 JP 2007501817A5 JP 2006522915 A JP2006522915 A JP 2006522915A JP 2006522915 A JP2006522915 A JP 2006522915A JP 2007501817 A5 JP2007501817 A5 JP 2007501817A5
Authority
JP
Japan
Prior art keywords
solution according
present
zinc
aqueous
aqueous pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006522915A
Other languages
English (en)
Japanese (ja)
Other versions
JP4750703B2 (ja
JP2007501817A (ja
Filing date
Publication date
Priority claimed from DE10337186A external-priority patent/DE10337186A1/de
Application filed filed Critical
Publication of JP2007501817A publication Critical patent/JP2007501817A/ja
Publication of JP2007501817A5 publication Critical patent/JP2007501817A5/ja
Application granted granted Critical
Publication of JP4750703B2 publication Critical patent/JP4750703B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006522915A 2003-08-13 2004-07-14 オキシメタゾリン及び/又はキシロメタゾリンを含有する医薬水溶液 Expired - Fee Related JP4750703B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10337186.9 2003-08-13
DE10337186A DE10337186A1 (de) 2003-08-13 2003-08-13 Wässrige Wirkstoff-Lösung
PCT/EP2004/007780 WO2005018601A1 (de) 2003-08-13 2004-07-14 Wässrige phramateuziche lösung enthaltend oxymetazolin und/oder xylometazolin

Publications (3)

Publication Number Publication Date
JP2007501817A JP2007501817A (ja) 2007-02-01
JP2007501817A5 true JP2007501817A5 (https=) 2007-09-06
JP4750703B2 JP4750703B2 (ja) 2011-08-17

Family

ID=34201503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522915A Expired - Fee Related JP4750703B2 (ja) 2003-08-13 2004-07-14 オキシメタゾリン及び/又はキシロメタゾリンを含有する医薬水溶液

Country Status (19)

Country Link
US (1) US20060222718A1 (https=)
EP (1) EP1663141B1 (https=)
JP (1) JP4750703B2 (https=)
KR (1) KR20060065677A (https=)
CN (1) CN100531733C (https=)
AT (1) ATE357212T1 (https=)
AU (1) AU2004266443A1 (https=)
BR (1) BRPI0413478A (https=)
CA (1) CA2535533C (https=)
CY (1) CY1107633T1 (https=)
DE (2) DE10337186A1 (https=)
DK (1) DK1663141T3 (https=)
ES (1) ES2282871T3 (https=)
MX (1) MXPA06001596A (https=)
PL (1) PL1663141T3 (https=)
PT (1) PT1663141E (https=)
RU (1) RU2343918C2 (https=)
WO (1) WO2005018601A1 (https=)
ZA (1) ZA200602071B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005075735A (ja) * 2003-08-28 2005-03-24 Rohto Pharmaceut Co Ltd オキシメタゾリン含有組成物
DE102007052380A1 (de) 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN101576539B (zh) * 2009-06-19 2012-05-23 广东省药品检验所 一种盐酸赛洛唑啉中杂质a的测定方法
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
DE102012005452A1 (de) * 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
US10598672B2 (en) 2014-02-18 2020-03-24 Cyrano Therapeutics, Inc. Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
US20170348230A1 (en) 2014-12-24 2017-12-07 Jadran-Galenski Laboratorij D.D A nasal composition containing sea water as stability-improving excipient
BR112018072177A2 (pt) * 2016-05-17 2019-02-12 Proponent Biotech Gmbh composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta
DE202017104738U1 (de) 2017-07-31 2018-08-01 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
CN107362141B (zh) * 2017-08-16 2018-06-05 深圳大佛药业股份有限公司 一种盐酸羟甲唑啉鼻喷雾剂及其制备方法
US20210244710A1 (en) * 2018-07-02 2021-08-12 Kangping Xiao Stable pharmaceutical formulations of oxymetazoline
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
JP7606530B2 (ja) 2020-03-24 2024-12-25 シラノ セラピューティクス, インコーポレイテッド コロナウイルス感染症による化学感覚機能障害の治療
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof
CN117982422B (zh) * 2024-04-03 2024-07-26 深圳大佛药业股份有限公司 一种用于治疗鼻炎的喷雾剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478565A (en) * 1990-03-27 1995-12-26 Warner-Lambert Company Treatment of sinus headache
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
JPH11302184A (ja) * 1998-04-21 1999-11-02 Taisho Pharmaceut Co Ltd 点鼻用組成物
NL1011016C2 (nl) * 1999-01-13 2000-07-14 Dagra Pharma Bv Neusspray op basis van xylometazoline en kamille-extract.
AU765736B2 (en) * 1999-06-22 2003-09-25 Boehringer Ingelheim International Gmbh Stable xylometazoline and oxymetazoline solution
EP1328214A4 (en) * 2000-09-20 2009-07-29 Shahinian Lee Jr NASAL, INHALABLE AND LOCAL OPHTHALMIC PREPARATIONS AND MEDICATIONS WITH SPONTANEOUS CONSERVATION
RU2212235C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Капли назальные бризолин, обладающие сосудосуживающим, противовоспалительным и противоотечным действием

Similar Documents

Publication Publication Date Title
JP2007501817A5 (https=)
US11491151B2 (en) Compositions and kits useful for treatment of respiratory illness
JP2009536666A5 (https=)
JP2022166006A5 (https=)
JP2008526757A5 (https=)
JP2009545603A5 (https=)
CA2535533A1 (en) Aqueous pharmaceutical solution comprising oxymetazoline and/or xylometazoline
JPH09301858A (ja) グルコン酸クロルヘキシジン安定化水性薬剤
JP2017002035A5 (https=)
JP2006516272A5 (https=)
JP2009544665A5 (https=)
RU2014114512A (ru) Водные композиции, содержащие арбекацин
RU2010146948A (ru) Железо- и цинксодержащая фармацевтическая композиция для лечения дефицита железа
JP2024040421A5 (https=)
RU2008110644A (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
PE20030970A1 (es) Formulacion de aerosol para inhalacion que contiene una sal de tiotropio
RU2009147458A (ru) Концентрат эсмолола
JP5314014B2 (ja) テルビブジンを含む医薬内用液
HRP20210178T1 (hr) Preparati za oralnu njegu koji sadrže klorheksidin i arginin ili njihove soli
JP2022187495A5 (https=)
JP2023527358A5 (https=)
JP5922609B2 (ja) 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性組成物
JP2018529674A5 (https=)
JP2002284673A (ja) 生理学的に許容可能な水溶液の調製法およびこの方法により得られた溶液
JP2006505499A5 (https=)